Alvotech WarrantALVOW
About: Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
Employees: 1,032
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
10% more funds holding
Funds holding: 10 [Q4 2024] → 11 (+1) [Q1 2025]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q4 2024] → 1 (+0) [Q1 2025]
0.02% less ownership
Funds ownership: 1.87% [Q4 2024] → 1.85% (-0.02%) [Q1 2025]
52% less capital invested
Capital invested by funds: $16.3M [Q4 2024] → $7.8M (-$8.5M) [Q1 2025]
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Research analyst outlook
We haven’t received any recent analyst ratings for ALVOW.
Financial journalist opinion
We haven’t received any recent news articles for ALVOW.